| Andrea Pedersen, | |
|
890 Lazelle St, Sturgis, SD 57785-1611 | |
| (605) 720-2400 | |
| Not Available |
| Full Name | Andrea Pedersen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 890 Lazelle St, Sturgis, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891239513 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | CP001173 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monument Health Spearfish Hospital | Spearfish, SD | Hospital |
| Monument Health Sturgis Hospital | Sturgis, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monument Health Network Inc | 5991616427 | 143 |
News Archive
IDRI (Infectious Disease Research Institute) announced today the start of a clinical trial in Sudan to test its leishmaniasis vaccine candidate for the treatment of post kala-azar dermal leishmaniasis (PKDL), a complication of visceral leishmaniasis (VL) which is observed in 50% of patients treated for VL in the country, predominantly affecting children.
GPs are not always using the most comprehensive and reliable online resources to support them in treating patients with the debilitating hearing condition tinnitus, researchers have found.
The psychologic response to terminal illness can be summarized as the realization that life is short, say Spanish researchers.
Cancer screening could soon be as simple as giving a urine sample using a patented device developed by a Missouri University of Science and Technology researcher. This week, Wyoming-based Cancer.im Inc., a Viratech Corp. company and social network for cancer patients, survivors and caretakers, announced an agreement with Missouri S&T to commercialize the device.
An international team including scientists from the University of Saskatchewan-Saskatoon Health Region and University of British Columbia, with the help of Saskatchewan Mennonite families, has identified an abnormal gene which leads to Parkinson's disease.
› Verified 7 days ago
| Entity Name | Monument Health Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588185268 PECOS PAC ID: 5991616427 Enrollment ID: O20031111000854 |
News Archive
IDRI (Infectious Disease Research Institute) announced today the start of a clinical trial in Sudan to test its leishmaniasis vaccine candidate for the treatment of post kala-azar dermal leishmaniasis (PKDL), a complication of visceral leishmaniasis (VL) which is observed in 50% of patients treated for VL in the country, predominantly affecting children.
GPs are not always using the most comprehensive and reliable online resources to support them in treating patients with the debilitating hearing condition tinnitus, researchers have found.
The psychologic response to terminal illness can be summarized as the realization that life is short, say Spanish researchers.
Cancer screening could soon be as simple as giving a urine sample using a patented device developed by a Missouri University of Science and Technology researcher. This week, Wyoming-based Cancer.im Inc., a Viratech Corp. company and social network for cancer patients, survivors and caretakers, announced an agreement with Missouri S&T to commercialize the device.
An international team including scientists from the University of Saskatchewan-Saskatoon Health Region and University of British Columbia, with the help of Saskatchewan Mennonite families, has identified an abnormal gene which leads to Parkinson's disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Pedersen, Po Box 401, Spearfish, SD 57783-0401 Ph: (605) 641-6781 | Andrea Pedersen, 890 Lazelle St, Sturgis, SD 57785-1611 Ph: (605) 720-2400 |
News Archive
IDRI (Infectious Disease Research Institute) announced today the start of a clinical trial in Sudan to test its leishmaniasis vaccine candidate for the treatment of post kala-azar dermal leishmaniasis (PKDL), a complication of visceral leishmaniasis (VL) which is observed in 50% of patients treated for VL in the country, predominantly affecting children.
GPs are not always using the most comprehensive and reliable online resources to support them in treating patients with the debilitating hearing condition tinnitus, researchers have found.
The psychologic response to terminal illness can be summarized as the realization that life is short, say Spanish researchers.
Cancer screening could soon be as simple as giving a urine sample using a patented device developed by a Missouri University of Science and Technology researcher. This week, Wyoming-based Cancer.im Inc., a Viratech Corp. company and social network for cancer patients, survivors and caretakers, announced an agreement with Missouri S&T to commercialize the device.
An international team including scientists from the University of Saskatchewan-Saskatoon Health Region and University of British Columbia, with the help of Saskatchewan Mennonite families, has identified an abnormal gene which leads to Parkinson's disease.
› Verified 7 days ago
Stephanie Davis, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2140 Junction Ave, Sturgis, SD 57785 Phone: 605-720-2600 | |
Jamie Krueger, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2140 Junction Ave, Sturgis, SD 57785 Phone: 605-720-2460 Fax: 605-720-0340 | |
Mrs. Lindsey Rose Robinson, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2140 Junction Ave, Sturgis, SD 57785 Phone: 605-720-2600 |